FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084319 [Registered on: 07/04/2025] Trial Registered Prospectively
Last Modified On: 04/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Medical Device
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparing Hemodynamic Stress Responses: Conventional Awake Extubation vs. I-Gel® Exchange Extubation in Craniotomy Surgeries 
Scientific Title of Study   A Randomized Study To Compare The Hemodynamic Stress Response Between Conventional Awake Extubation Of Endotracheal Tube And I-GEL® Exchange Extubation During Emergence From General Anaesthesia In Craniotomy Surgeries  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR Huda Subair 
Designation  DNB RESIDENT,ANAESTHESIOLGY 
Affiliation  RUKMANI BIRLA HOSPITAL, A UNIT OF CMRI , JAIPUR 
Address  DEPARTMENT OF ANAESTHESIA FIRST FLOOR CK BIRLA HOSPITALS,RBH GOPALPURA BYPASS ROAD NEAR TRIVENI FLYOVER GOPALPURA JAIPUR

Jaipur
RAJASTHAN
302018
India 
Phone  8289907933  
Fax    
Email  drhudasubair@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ruchi Baid 
Designation  Additional Director, Department of Anaesthesia 
Affiliation  RUKMANI BIRLA HOSPITAL, A UNIT OF CMRI , JAIPUR 
Address  Rukmani Birla Hospital, Gopalpura Bypass Road, Near Triveni Bridge, Gopalpura, Jaipur

Jaipur
RAJASTHAN
302018
India 
Phone  9828119109  
Fax    
Email  drruchibaid@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR HUDA SUBAIR 
Designation  DNB RESIDENT,ANAESTHESIOLGY 
Affiliation  RUKMANI BIRLA HOSPITAL, A UNIT OF CMRI , JAIPUR 
Address  Rukmani Birla Hospital, Gopalpura Bypass Road, Near Triveni Bridge, Gopalpura, Jaipur

Jaipur
RAJASTHAN
302018
India 
Phone  8289907933  
Fax    
Email  drhudasubair@gmail.com  
 
Source of Monetary or Material Support  
Rukmani Birla Hospital,A unit of Calcutta Medical Research Institute 
 
Primary Sponsor  
Name  Rukmani Birla Hospital  
Address  Rukmani birla hospital,a unit of CMRI Jaipur 302018 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Huda Subair  RUKMANI BIRLA HOSPITAL  Department of Anaesthesia, Gopalpura Bypass Rd, Near Triveni Flyover, Shanthi Nagar, Gopal Pura Mode, Jaipur, Rajasthan 302018 CK Birla Hospitals RBH,
Jaipur
RAJASTHAN 
8289907933

drhudasubair@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
RUKMANI BIRLA HOSPITAL INSTITUIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G939||Disorder of brain, unspecified, (2) ICD-10 Condition: G94||Other disorders of brain in diseases classified elsewhere,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Conventional Awake Extubation of Endotracheal Tube  After completion of craniotomy surgery under general anaesthesia ,patient is extubated in the conventional manner. 
Intervention  I-GEL® Exchange Extubation Technique  Before extubation, an appropriately sized I-gel® will be placed behind the tracheal tube, while the lungs are ventilated with the maintenance mixture and end tidal sevoflurane concentration is maintained at 0.6 -1.2%. Lubricated gastric tube is inserted through the gastric channel so as to ensure correct placement of SAD and also to prevent aspiration. After confirmation of adequate placement of SAD clinically and the correct placement of I-gel® with adequate chest rise and via capnography, the ventilation is continued. An assistant then deflates the tracheal tube cuff and removes the endotracheal tube while maintaining positive pressure. Thus, patient is allowed to be ventilated through the I-gel® as muscle relaxation is reversed . Once the patient is awake and breathing spontaneously, the I-gel® is removed.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  With consent for the procedure, ASA grade 1 & 2,Age group 18 to 60 years,Modified Mallampati grade 1 and 2, Undergoing general anaesthesia for elective craniotomy surgeries,Tumor size less than 4cm,Aneurysm,Modified Fischer grade 1 or 2,Surgical duration less than 4 hours,Blood loss less than 400ml,Fasting greater than or equal to 8 hours,BMI less than 30 
 
ExclusionCriteria 
Details  Refusal to give consent,History of allergic drug reaction to any of the proposed drugs set to be used during the procedure,Patients with anticipated difficult intubation,Glasgow coma score less than 15, ASA grade 3,4 and 5, Patients with signs of increased ICP
Volumes greater than 1.5ml per kg on ultrasound guided gastric antrum examination, History of congestive heart failure, uncontrolled hypertension, uncontrolled diabetes mellitus, acute respiratory distress syndrome, psychiatric illness, bleeding disorder, hepatic or renal dysfunction
Patients who may need elective mechanical ventilation post operatively
Patients who are receiving IV beta blockers
Pregnancy 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
The change in Heart Rate,Systolic Blood Pressure, Diastolic Blood Pressure and Mean Arterial Blood Pressure.   The parametres were measured At the end of surgery, After reversal, 1 minute after reversal, 3 minutes after reversal, 5 minutes after reversal, 10 minutes after reversal, 15 minutes after reversal,1 hour post operatively and 6 hours post operatively.
 
 
Secondary Outcome  
Outcome  TimePoints 
To compare the total doses of intravenous Diltiazem required in each group to maintain hemodynamic parameters (Heart Rate & Mean Arterial Pressure) within 20% of baseline values during the extubation period.

To evaluate the incidence of respiratory complications following withdrawal of general anaesthesia, such as bucking, coughing, desaturation, laryngospasm, & pulmonary edema. 
Intravenous Diltiazem will be administered At the end of surgery, after reversal, 1 minute after reversal,3 minutes after reversal, 5 minutes after reversal, 10 minutes after reversal & 15 minutes after reversal.



 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response (Others) -  BY CONTACTING VIA EMAIL: drhudasubair@gmail.com

  6. For how long will this data be available start date provided 07-02-2025 and end date provided 07-05-2026?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - nil
Brief Summary  

This randomized comparative study aims to compare the hemodynamic stress response between conventional awake extubation of endotracheal tube (ETT) and I-gel® exchange extubation during emergence from general anesthesia in craniotomy surgeries. The study includes 70 patients undergoing elective craniotomy surgeries, divided into two groups: Group A (conventional awake endotracheal extubation, n=35) and Group B (extubation using Bailey’s maneuver over I-gel®, n=35). The study will be conducted at the department of Anesthesiology,

C. K. BIRLA Hospital, RBH, Jaipur.

 
Close